Elevated total bile acid levels as an independent predictor of mortality in pediatric sepsis

Yanfei Wang1, Kelei Deng1, Peiquan Lin1

  • 1Department of Surgical ICU, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.

Pediatric Research
|September 12, 2024
PubMed

Insights

Elevated total bile acid (TBA) levels are linked to increased mortality risk in pediatric sepsis. Higher TBA levels in critically ill children predict a poorer prognosis, highlighting its potential as a biomarker.

Area of Science:

  • Pediatric critical care medicine
  • Metabolomics and gut microbiome research
  • Sepsis pathophysiology

Background:

  • Growing evidence links bile acid (BA) metabolism to sepsis.
  • The roles of the gut microbiome and metabolomics in sepsis are increasingly understood.

Purpose of the Study:

  • To investigate the association between bile acid metabolism and sepsis outcomes in children.
  • To identify potential biomarkers for predicting sepsis mortality in pediatric patients.

Main Methods:

  • A cohort study involving pediatric sepsis patients and non-infectious controls.
  • Clinical data collection and statistical analysis were performed.

Main Results:

  • Total bile acid (TBA) levels were elevated in both early and severe pediatric sepsis.
  • TBA was identified as a significant risk factor for sepsis and an independent predictor of mortality.
  • A clinical model using TBA (>17.95 µmol/L) showed high accuracy (AUC 0.842) in predicting sepsis mortality.

Conclusions:

  • Elevated serum TBA levels are associated with increased mortality risk in pediatric sepsis.
  • Serum TBA levels can serve as a valuable biomarker for predicting sepsis prognosis in children.
  • Significant differences in TBA levels were observed between sepsis survivors, non-infected controls, and those with fatal outcomes.
Abstract